Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• Caspases in Myocardial Infarction.Deamidated Gliadin Peptides as Targets for Celiac Disease Specific Antibodies.Urokinase Receptor Variants in Tissue and Body Fluids.Proteomics in Cancer.Paraneoplastic Neurological Syndromes and Oncnerual Antibodies: Clinical and Immunological Aspects.Pathophysiologic Mechanisms of Angiogenesis.Bikunin (Urinary Trypsin Inhibitor): Structure, Biological Relevance and Measurement.Gene Expression Assays.

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• Caspases in Myocardial Infarction.Deamidated Gliadin Peptides as Targets for Celiac Disease Specific Antibodies.Urokinase Receptor Variants in Tissue and Body Fluids.Proteomics in Cancer.Paraneoplastic Neurological Syndromes and Oncnerual Antibodies: Clinical and Immunological Aspects.Pathophysiologic Mechanisms of Angiogenesis.Bikunin (Urinary Trypsin Inhibitor): Structure, Biological Relevance and Measurement.Gene Expression Assays.

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• Caspases in Myocardial Infarction.Deamidated Gliadin Peptides as Targets for Celiac Disease Specific Antibodies.Urokinase Receptor Variants in Tissue and Body Fluids.Proteomics in Cancer.Paraneoplastic Neurological Syndromes and Oncnerual Antibodies: Clinical and Immunological Aspects.Pathophysiologic Mechanisms of Angiogenesis.Bikunin (Urinary Trypsin Inhibitor): Structure, Biological Relevance and Measurement.Gene Expression Assays.